United States
Germany
Japan
United Kingdom
China
SARS-CoV monoclonal antibody (CR3022 biosimilar)
| Applications | ELISA, FC |
| Reactivities | SARS-CoV-2 |
Products
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))
| Applications | ELISA |
| Reactivities | Human |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
| Applications | FC |
| Reactivities | Human, Monkey |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
